| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |